Background Studies of antiretroviral therapy (ART) use during pregnancy in HIV-infected
women have suggested that ART exposure may be associated with adverse birth outcomes …

Aims In 2018, 1.07 million pregnant women received antiretroviral drugs, raising whether
this affects pregnancy outcomes. We assessed the adverse pregnancy outcomes associated …

Background: Adverse pregnancy outcomes such as preterm birth (PTB), low birth weight
(LBW), and small for gestational age (SGA) remain major global problems. We compared …

Objective The objective of the study was to compare pregnancy outcomes according to
maternal antiretroviral treatment (ART) regimens. Design A retrospective cohort study …

The majority of pediatric human immunodeficiency virus (HIV) infections are the result of
vertical transmissions that occur during pregnancy, childbirth, and breastfeeding. The …

Background: There is limited description of the feeding characteristics of infants with
unrepaired cleft lip and palate, exposed to HIV, but not necessarily infected. Objective: To …

Efavirenz is recommended as a preferred first-line drug for women of childbearing potential
living with human immunodeficiency virus. Efavirenz is known for its central nervous system …

Background There is a knowledge gap on the clinical use of elvitegravir (EVG) during
pregnancy and maternal viral suppression. Our objective was to evaluate the effects of EVG …

Combination antiretroviral regimens have achieved tremendous success in reducing
perinatal HIV transmission, and have become standard of care in pregnant women with HIV …

Introduction: In the past decade, mobile telephone use has surged in sub-Saharan Africa,
creating new opportunities in health care. Mobile telephone interventions have been used in …